Search results

The authors aimed to examine the presence and character of inter- and intra-approaches to replication studies published in five leading marketing journals (Journal of Marketing, Journal of Marketing Research, Journal of Public Policy & Marketing, Marketing Science, Journal of the Academy of Marketing Science) across four decade intervals (i.e. 1980s, 1990s, 2000s and 2010/2011). The research sought answers to three research questions.

Content analysis of a randomly selected sample of 2,717 articles found 128 replicative studies in the journal issues. Comparisons of the replication approaches of the studies address two issues: the criticism that intra-study replication is not true replication as it is inconsistent with the criterion of researcher independence and the reported outcomes of the replicative studies relative to those of the original studies.

Overall, the presence of replications increased over time; however, the increase was attributable primarily to the number of intra-study replications published in two decades, the 2000s and 2010/2011 intervals. Conflicting findings infrequently appeared in the replication studies regardless of approach, indicating the possible existence of confirmation bias in the marketing literature.

Replication in marketing is either improving or stagnant depending on the accepted definition of replication. Of special importance, given the questioning of the intra-study approach as true replicative research, more replicated findings produced by independent researchers are needed to establish theoretical validity of marketing knowledge for use by both marketing academicians and decision makers.

To determine how seniors evaluate, compare, and use prescription drug information sources, provide insight on perceptions of the credibility, trustworthiness, and value of these sources, and capture verbatim comments for translation into scalar statements in future surveys.

A total of 25 in‐depth interviews were conducted with US seniors age 65 or older. The transcripts were analyzed using an interpretative approach.

Informants distinguish between sources on the dimension of credibility; place the most trust in physicians but since they tend to experience a lack of time and attention from them, mass media seem to fill an information gap; and direct‐to‐physician promotions appear to have an indirect influence on patients' perceived credibility of and interaction with physicians.

The findings suggest that identification of key sources should consider two factors: frequency of access/utilization and trust in information provided by the source. The findings also provide empirically‐grounded statements for future scale development.

The results suggest that for multi‐media campaign effectiveness: advertising for a new drug may be most effective on TV but as a brand enters growth or maturity, print may be a better option; marketers should emphasize print in the direct‐to‐consumer (DTC) advertising media mix; sampling strategies should be coordinated with product packaging literature and emphasized to promote trial; and marketers should attempt to increase internet usage among seniors and utilize the medium more actively but avoid online advertising.

The findings contribute to knowledge on the responsiveness of US seniors to DTC advertising and other prescription drug information sources.

The over‐the‐counter (OTC) drug market is highly competitive, and consumer advertising is a prominent influence in OTC drug purchase and consumption. Given current marketplace conditions, it is important to summarize OTC drug advertising research. This paper aims to review the state of the public research literature on OTC drug advertising and provide a research agenda derived from the findings.

A literature review was conducted to identify the key themes in OTC drug advertising research and secondary data were collected about the regulation, nature, functions, and scope of OTC drug advertising.

Most pharmaceutical advertising studies have focused on prescription drugs, including the majority of direct‐to‐consumer advertising investigations. OTC drug advertising has received considerably less empirical attention. Since the mid‐1970s, only 24 OTC drug advertising studies have appeared sporadically in the literature. The cumulative findings are interesting and suggestive but dated, fragmented, and incomplete. Though research interest has waned, OTC drug markets and advertising spending have not. Advertising remains a prominent OTC drug purchase and consumption driver, likely spurred on by self‐medication and Rx‐to‐OTC drug switching. The state of the public research, the social and policy implications of self‐medication, and the growing OTC drug market signal that it is time to revisit OTC drug advertising content, processes, and effects.

The paper puts the subject of OTC drug advertising back on the radar of communication, advertising, and pharmaceutical marketing researchers and offers an agenda of research questions derived from the reviewed literature to guide and stimulate future studies.

Advertisers have been criticized for underrepresenting the elderly in print ads and television commercials. What critics often overlook, however, are audience and product considerations along with the effectiveness of older spokespersons in influencing intent to purchase among elderly and younger consumers. This article examines what is currently known about the use of older persons in advertising and extends these findings by reporting the views of advertising agency executives on this topic. From the results of these studies, an audience‐product matrix with examples is provided to help put the advertiser's position into perspective. According to the literature reviewed and the perceptions of advertising agency executives, the use of elderly spokespersons tends to work best when the product or service can be targeted to elderly consumers and the products or services themselves are elderly‐oriented. There is some evidence to suggest that elderly persons are used in advertisements not because advertisers want to represent the elderly, but rather when these spokespersons can sell the product.

Salespeople assume legal obligations every time they talk with a potential buyer. Obviously, the sales manager is ultimately accountable for these obligations. It is crucial, then, that the sales manager and the sales force of today be cognizant of the part a sales presentation may play in creating a legal warranty. The sales manager must be conscious of the increasing legal penetration into the sales area. It is more and more difficult to direct the sales force to give one's product every available edge, yet stay within the boundaries of the law. The sales manager, therefore, should make all salespeople aware of the legal implications of what they communicate to the customer. In addition, the sales force must realize the importance of its sales delivery in view of the law. There is no excuse for ignorance, for there is an abundance of information available in the form of books, periodicals, and government documents. Care must be taken to insure that the required restraints on ambitious salespeople doesn't weaken their spirits and morale — resulting in fewer sales — but the costs and legal suits avoided, and the good‐will that is retained may more than compensate. Prior to dealing with the specifics of the salesperson's behavior and its legal implications, the pertinent portions of the Uniform Commercial Code are briefly reviewed.

Although it is widely acknowledged that health care delivery systems are complex adaptive systems, there are gaps in understanding the application of systems engineering approaches to systems analysis and redesign in the health care domain. Commonly employed methods, such as statistical analysis of risk factors and outcomes, are simply not adequate to robustly characterize all system requirements and facilitate reliable design of complex care delivery systems. This is especially apparent in institutional-level systems, such as patient safety programs that must mitigate the risk of infections and other complications that can occur in virtually any setting providing direct and indirect patient care. The case example presented here illustrates the application of various system engineering methods to identify requirements and intervention candidates for a critical patient safety problem known as failure to rescue. Detailed descriptions of the analysis methods and their application are presented along with specific analysis artifacts related to the failure to rescue case study. Given the prevalence of complex systems in health care, this practical and effective approach provides an important example of how systems engineering methods can effectively address the shortcomings in current health care analysis and design, where complex systems are increasingly prevalent.

In order to succeed in an action under the Equal Pay Act 1970, should the woman and the man be employed by the same employer on like work at the same time or would the woman still be covered by the Act if she were employed on like work in succession to the man? This is the question which had to be solved in Macarthys Ltd v. Smith. Unfortunately it was not. Their Lordships interpreted the relevant section in different ways and since Article 119 of the Treaty of Rome was also subject to different interpretations, the case has been referred to the European Court of Justice.